SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Munch-a-Biotech Today

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mike McFarland who wrote (202)2/23/1999 7:47:00 PM
From: jeffbas  Read Replies (2) of 3158
 
You are correct and I apologize for posting that here. GZMO is a very unlikely "munchee" at this time. I realized that after posting and put it on the GZMO thread. I am still trying to find the right combination of thread and competence to post to for intelligent discussions in biotech.

In fact, I think that GENZ is a potential "muncher", with GZMO getting to munch anything directly in their area -- just like TMO did
with many of their acquisitions.

Richard, even swampland in the right part of Orlando had its value <ggg>. I just happen to believe that the GENZ relationship is worth the current GZMO market cap. I think that the TMO model is relatively more valuable to GZMO in this industry than it was to say THI in the instrument business (and I watched it work for TMO over a 20 year period). The model is not exactly the same but it is similar.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext